Oncology pharmacology has seen rapid progress with the advent of targeted therapies, immunotherapies, and precision medicine. This book explores the latest advances in cancer pharmacology, covering novel drug classes, biomarkers, and combination treatments. It addresses challenges such as drug resistance and toxicity, offering insights into the future of personalized oncology care. Essential for oncologists, researchers, and healthcare professionals, this book bridges scientific innovation with clinical application.
Jacob Daniels is an expert dermatologist specializing in recent advances in oncology pharmacology, focusing on the development of new pharmacological treatments for skin cancers and other oncological skin conditions. His research investigates targeted therapies, immunotherapies, and combination treatments aimed at improving outcomes for patients with melanoma, basal cell carcinoma, and other skin malignancies. Jacob has published extensively on the efficacy, safety, and innovative mechanisms of new oncological drugs in dermatology. He has developed comprehensive oncology pharmacology protocols that enhance treatment efficacy and patient safety.